ofloxacin has been researched along with Duodenal Ulcer in 5 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 7.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| " The therapeutic combination of H2-receptor-antagonists (= H2-RA) and ofloxacin (Tarivid) has shown to heal resistant duodenal ulcers in some preliminary cases, which did not respond to a three month standard dosage treatment with H2-RA." | 5.27 | [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study]. ( Bayerdörffer, E; Kasper, G; Ottenjann, R; Pirlet, T; Sommer, A, 1988) |
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 3.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| " The therapeutic combination of H2-receptor-antagonists (= H2-RA) and ofloxacin (Tarivid) has shown to heal resistant duodenal ulcers in some preliminary cases, which did not respond to a three month standard dosage treatment with H2-RA." | 1.27 | [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study]. ( Bayerdörffer, E; Kasper, G; Ottenjann, R; Pirlet, T; Sommer, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, M | 1 |
| Jacob, JJ | 1 |
| Kapoor, R | 1 |
| Abraham, J | 1 |
| Zelenková, J | 1 |
| Toman, R | 1 |
| Bielaszewská, M | 1 |
| Hanika, J | 1 |
| Zeman, V | 1 |
| Bayerdörffer, E | 3 |
| Simon, T | 1 |
| Bästlein, C | 1 |
| Ottenjann, R | 3 |
| Kasper, G | 3 |
| Pirlet, T | 2 |
| Sommer, A | 2 |
2 trials available for ofloxacin and Duodenal Ulcer
| Article | Year |
|---|---|
Bismuth/ofloxacin combination for duodenal ulcer.
Topics: Anti-Infective Agents; Bismuth; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Co | 1987 |
[Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
Topics: Adult; Aged; Aged, 80 and over; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Co | 1987 |
3 other studies available for ofloxacin and Duodenal Ulcer
| Article | Year |
|---|---|
Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fatal O | 2008 |
[Campylobacter pylori and treatment of duodenal ulcer].
Topics: Adult; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Female; Gastritis; Humans; Male; Mid | 1990 |
[Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].
Topics: Adult; Aged; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Duodeno | 1988 |